Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease
Sleep Medicine · 2023
DOI: 10.1016/j.sleep.2023.06.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep Medicine, 2023. Verfasst von Q Lisan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM, UMR-S970, Paris Cardiovascular Research Center, Team "Integrative Epidemiology of Cardiovascular Diseases", Paris, Fra…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, MicroRNAs, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: while obstructive sleep apnea is strongly associated with incident cardiovascular diseases (CVD), the underlying mechanisms remain to be elucidated. This study aimed to compare the patterns of microRNAs expression between OSA and control patients with and without incident CVD. METHODS: 218 matched adult participants with and without OSA and with and without incident CVD were selected from two independent community-based prospective cohorts in France and Switzerland, and 168 microRNAs on average were detected per sample. OSA was diagnosed using the validated Berlin questionnaire in one study (Paris Prospective Study 3) and during a full-night polysomnography in the second study (HypnoLaus Study). RESULTS: there were 78 OSA patients (39 with and 39 without CVD) and 140 controls (70 with and 70 without CVD). Participants were male in 54.6% (n = 119) and mean age was 58.7 years (±9.2). Of the 183 miRNAs screened, a mean 168 assays were detected per sample, and 129 in all samples. There was no pattern of blood microRNAs expression that discriminated OSA patients with and without CVD events. CONCLUSIONS: this binational study failed to find any association between a large panel of microRNAs and OSA patients with and without incident CVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, INSERM, UMR-S970, Paris Cardiovascular Research Center, Team "Integrative Epidemiology of Cardiovascular Diseases", Paris, France; Department of Head and Neck Surgery, Foch Hospital, Suresnes, Fra…
- Department of Medicine, Internal Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
- Preventive and Clinical Investigation Center, Paris, France.
- Université Paris Cité, INSERM, UMR-S970, Paris Cardiovascular Research Center, Team "Cellular, Molecular and Physiological Mechanisms of Heart Failure', Paris, France.
- Université Paris Cité, INSERM, UMR-S970, Paris Cardiovascular Research Center, Team "Integrative Epidemiology of Cardiovascular Diseases", Paris, France.
- Center for Investigation and Research in Sleep (CIRS), Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
Zitieren
APA
Lisan, Q., Marques-Vidal, P., Hausler, N., Danchin, N., Boutouyrie, P., Asselin, A., Jouven, X., Heinzer, R., & Empana, J. P. (2023). Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease. Sleep Medicine. https://doi.org/10.1016/j.sleep.2023.06.006
Vancouver
Lisan Q, Marques-Vidal P, Hausler N, Danchin N, Boutouyrie P, Asselin A, et al. Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease. Sleep Medicine. 2023. doi:10.1016/j.sleep.2023.06.006
BibTeX
@article{Lisan2023,
author = {Lisan, Q and Marques-Vidal, P and Hausler, N and Danchin, N and Boutouyrie, P and Asselin, A and Jouven, X and Heinzer, R and Empana, J P},
title = {Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease},
journal = {Sleep Medicine},
year = {2023},
doi = {10.1016/j.sleep.2023.06.006}
}
EUVIMED